• This signaling framework represents a new non-canonical regulation of mTOR activity that is independent of AKT and could be a novel mechanism underpinning the action of a variety of G protein-coupled receptors that are linked to the mTOR signaling network. (bvsalud.org)
  • Restoration of receptor expression using adenovirus containing the GcgR cDNA restored hepatic GcgR, phospho-cAMP response element binding protein (P-CREB), and phosphoenol pyruvate carboxykinase, markers of glucagon action, rose dramatically and severe hyperglycemia appeared. (elsevierpure.com)
  • Longer-term (24 and 48 h) treatment reduced the expression of lipogenic markers (FA synthase and sterol regulatory element-binding protein-1) and increased the expression of lipolytic [hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)] and mitochondrial (peroxisome proliferator-activated receptor γ coactivator-1α and carnitine palmitoyltransferase 1) markers. (academic-accelerator.com)
  • The expression levels of LPL (lipoprotein lipase), HSL (Hormone-sensitive lipase), FAS (fatty acid synthase), and PPARα/PPARγ (peroxisome proliferator-activated receptor alpha/gamma) were significantly changed in the sheep preadipocytes during differentiation for 7 days. (academic-accelerator.com)
  • 05) expression of peroxisome proliferator-activated receptor α (PPARα) and expressions for Ppara and hormone sensitive lipase (HSL) in the liver of IUGR-C rats than the IUGR rats. (academic-accelerator.com)
  • To determine unambiguously if suppression of glucagon action will eliminate manifestations of diabetes, we expressed glucagon receptors in livers of glucagon receptor-null (GcgR -/- ) mice before and after β-cell destruction by high-dose streptozotocin. (elsevierpure.com)
  • In conclusion, the metabolic manifestations of diabetes cannot occur without glucagon action and, once present, disappear promptlywhen glucagon action is abolished. (elsevierpure.com)
  • We hypothesized that disruption of glucagon receptor signaling would lead to an increased plasma concentration of amino acids, which in a feedback manner stimulates the secretion of glucagon, eventually associated with compensatory proliferation of the pancreatic alpha-cells. (ku.dk)
  • Among these so-called counterregulatory responses, secretion of glucagon from pancreatic α-cells is preeminent. (bvsalud.org)
  • Glucagon secreted from the pancreatic alpha-cells is essential for regulation of blood glucose levels. (ku.dk)
  • Apart from their hyperaminoacidemia, Gcgr-/- mice display hyperglucagonemia, increased pancreatic content of glucagon and somatostatin (but not insulin), and alpha-cell hyperplasia and hypertrophy compared with WT littermates. (ku.dk)
  • The downregulated expression of pancreatic estrogen receptor α, androgen receptor, and transcription factor PDX1 was responsible for impacting ß-cell development. (bvsalud.org)
  • In anesthetized mice, a glucagon receptor-specific antagonist (Novo Nordisk 25-2648, 100 mg/kg) reduced amino acid clearance. (ku.dk)
  • Crystal structure of the human glucagon receptor (GCGR) in complex with the antagonist MK-0893. (guidetopharmacology.org)
  • Ac3IV (Ac-CYIQNCPRG-NH2) is an enzymatically stable vasopressin analogue that selectively activates Avpr1a (V1a) and Avpr1b (V1b) receptors. (bvsalud.org)
  • In recent years the role of altered alpha cell function and glucagon secretion in type 1 diabetes has attracted scientific attention. (bvsalud.org)
  • The crystal structure of the full-length human glucagon receptor in an inactive conformation in complex with a negative allosteric modulator NNC0640, and antigen-binding fragment (Fab) of an inhibitory antibody, mAb1. (guidetopharmacology.org)
  • The aim of this review is to (i) summarize current knowledge on glucagon responses during hypoglycemia in normal physiology and type 1 diabetes, and (ii) review human in vivo studies investigating glucagon responses after other stimuli in individuals with type 1 diabetes and nondiabetic individuals. (bvsalud.org)
  • Crotedumab, a GCGR antibody, alleviated metabolic derangements in a mouse model of WD-induced NASH. (biocytogen.com.cn)
  • Our data support the notion that glucagon secretion and hepatic amino acid metabolism are linked in a close feedback loop, which operates independently of normal variations in glucose metabolism. (ku.dk)
  • Glucagon, a hormone secreted in response to a lowering in glucose concentration, counteracts a further drop in glycemia by promoting gluconeogenesis and glycogenolysis in target tissues. (bvsalud.org)
  • However, glucagon may play an equally important role in the regulation of amino acid metabolism by promoting ureagenesis. (ku.dk)